← Back to Search

Behavioral Intervention

iDECIDE Program for Substance Abuse in Students

N/A

Recruiting

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Currently enrolled in middle or high school

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 1-month follow-up (primary) and 1-year follow-up (exploratory)

Awards & highlights

Study Summary

This trial will test how a drug education program affects 300 school students who have violated their school's substance use policies. Outcomes will measure knowledge, attitudes, willingness to quit/reduce use, and substance use behavior.

Who is the study for?

This trial is for middle and high school students who recently broke their school's rules about drugs. They need a parent or guardian to agree if they're under 18, must be able to visit the study site 9 times over a year, have internet access for Zoom meetings, and can't be in daily heavy drug use or have had intense drug treatment before.Check my eligibility

What is being tested?

The iDECIDE program aims to teach kids who've used substances better ways of thinking and acting instead of punishing them. About 300 students will either start this new program right away or wait (the control group) to see which helps more with their knowledge, attitudes, and actual substance use.See study design

What are the potential side effects?

Since iDECIDE is an educational curriculum rather than a medication, it doesn't have medical side effects. However, participants may experience emotional discomfort when discussing substance use behaviors.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a middle or high school student.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 1-month follow-up (primary) and 1-year follow-up (exploratory)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 1-month follow-up (primary) and 1-year follow-up (exploratory)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 1-month follow-up (primary) and 1-year follow-up (exploratory) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Frequency of Substance Use

Knowledge of Drug Effects and Brain Development

Perceived Harm of Substance Use

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: iDECIDEExperimental Treatment1 Intervention

Participants will… Receive 4 weekly sessions of the iDECIDE drug curriculum. Complete assessments and questionnaires, including self-reports of substance use and 4 urinalysis virtual visits. Be video recorded for quality control.

Group II: Waitlist Control GroupActive Control1 Intervention

Participants will… Not receive the iDECIDE curriculum during the weekly visits. They can choose to self-enroll in the iDECIDE curriculum at their one-month follow up visit. Undergo symptom monitoring during the weekly visits. Complete assessments and questionnaires, including self-reports of substance use and 4 urinalysis virtual visits.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor

2,935 Previous Clinical Trials

13,198,341 Total Patients Enrolled

5 Trials studying Substance Abuse

113,876 Patients Enrolled for Substance Abuse

Massachusetts Department of HealthOTHER_GOV

6 Previous Clinical Trials

8,565 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could people over the age of two decades become participants in this trial?

"Per the criteria for this medical trial, individuals aged 9 to 22 are eligible for enrollment."

Answered by AI

For whom is this clinical trial best suited?

"In order to participate in this clinical experiment, potential candidates must be suffering from substance abuse and aged between 9 and 22. This medical trial is hoping to enrol 300 applicants."

Answered by AI

Is there still opportunity to join this investigation as a participant?

"The information from clinicaltrials.gov states that this trial is not currently taking on new patients, with the initial posting being dated November 1st 2023 and the last update occurring October 30th 2023. Although no enrolment is happening for this study at present, 396 other trials are actively recruiting across the country."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students

Randi Melissa Schuster 2023. "A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06115746.